institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics development - Pharmafile

Summary by pharmafile.com
Oxford-based biotechnology company Ochre Bio has announced the appointment of Quin Wills as CEO. As co-founder of the company and previously its chief scientific officer, Wills has played a central role in shaping Ochre’s approach to developing RNA-based therapies for chronic liver disease. The appointment signals a new phase of growth for Ochre as it […] The post Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics deve…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Monday, June 30, 2025.
Sources are mostly out of (0)